Showing results (1401-1410 of 1,488) with videos related to

Sort By:
Pageof 149
European Urology Focus|September 28, 2017
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell CarcinomaJozefina Casuscelli, Maria F Becerra, Brandon J Manley, et al.
Cell Host & Microbe|September 14, 2018
The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota HomeostasisAgnieszka D Truax, Liang Chen, Jason W Tam, et al.
European Urology Focus|December 10, 2019
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical CourseRenzo G DiNatale, Alexander N Gorelick, Vladimir Makarov, et al.
Sports Medicine (Auckland, N.Z.)|May 19, 2024
Isometric Exercise Training and Arterial Hypertension: An Updated ReviewJamie J Edwards, Damian A Coleman, Raphael M Ritti-Dias, et al.
Nanotechnology|February 27, 2023
Thickness measurements of graphene oxide flakes using atomic force microscopy: results of an international interlaboratory comparisonTianjia Bu, Huifang Gao, Yaxuan Yao, et al.
Advanced Powder Technology : the International Journal of the Society of Powder Technology, Japan|December 5, 2017
Size and shape distributions of primary crystallites in titania aggregatesEric A Grulke, Kazuhiro Yamamoto, Kazuhiro Kumagai, et al.
Radiation Research|January 28, 2022
Predictive Radiation Oncology - A New NCI-DOE Scientific Space and CommunityJeffrey C Buchsbaum, David A Jaffray, Demba Ba, et al.
JAMA Network Open|October 19, 2020
Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical TrialDaniel Rooks, Therese Swan, Budhaditya Goswami, et al.
European Urology Focus|July 30, 2017
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell CarcinomaBrandon John Manley, Emily C Zabor, Jozefina Casuscelli, et al.
Cancers|June 27, 2024
A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE TrialArvin K George, Ranko Miocinovic, Amit R Patel, et al.
Pageof 149